|
市場調査レポート
商品コード
1381604
放射線治療の世界市場:製品、手技、用途、エンドユーザー別-2023-2030年予測Radiotherapy Market by Product, Procedure, Application, End-User - Global Forecast 2023-2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
放射線治療の世界市場:製品、手技、用途、エンドユーザー別-2023-2030年予測 |
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
|
放射線治療の世界市場は、2022年の70億1,000万米ドルから2030年には125億2,000万米ドルに達すると予測され、予測期間中のCAGRは7.51%です。
放射線治療の世界の世界市場
主な市場の統計 | |
---|---|
市場金額:基準年[2022] | 70億1,000万米ドル |
推定市場金額[2023] | 75億4,000万米ドル |
予測市場金額[2030] | 125億2,000万米ドル |
CAGR(%) | 7.51% |
FPNVポジショニングマトリックスは放射線治療の世界市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。
市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。
1.市場の浸透度:主要企業の市場力学と製品に関する包括的な情報を提供します。
2.市場の開拓度:新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。
3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。
4.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。
5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。
1.放射線治療の世界市場の市場規模および予測は?
2.放射線治療の世界市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は?
3.放射線治療の世界市場における競争戦略の窓とは?
4.放射線治療の世界市場の最新技術動向と規制の枠組みは?
5.放射線治療の世界市場における主要ベンダーの市場シェアは?
6.放射線治療の世界市場への参入に適した形態や戦略的手段は?
The Radiotherapy Market is projected to reach USD 12.52 billion by 2030 from USD 7.01 billion in 2022, at a CAGR of 7.51% during the forecast period.
Global Radiotherapy Market
KEY MARKET STATISTICS | |
---|---|
Base Year Value [2022] | USD 7.01 billion |
Estimated Year Value [2023] | USD 7.54 billion |
Forecast Year Value [2030] | USD 12.52 billion |
CAGR (%) | 7.51% |
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Radiotherapy Market.
Based on Product, market is studied across Conventional Cobalt-60 Teletherapy Units, Conventional Linear Accelerators, Electron-Emitting High-Energy Linear Accelerators, External Beam Radiotherapy, Internal Beam Radiotherapy or Brachytherapy, Particle Therapy Systems, Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators, and Systemic Radiotherapy. The Internal Beam Radiotherapy or Brachytherapy is further studied across Afterloaders, Applicators, and IORT Systems. The Particle Therapy Systems is further studied across Cyclotrons, Synchrocyclotron, and Synchrotrons. The Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators is further studied across CyberKnife, Gamma Knife, and TomoTherapy. The Systemic Radiotherapy is further studied across Iobenguane (I-131), Rhenium-186, and Samarium-153. The External Beam Radiotherapy is projected to witness significant market share during forecast period.
Based on Procedure, market is studied across External Beam Radiotherapy, Instillation Radiotherapy, Internal Beam Radiotherapy or Brachytherapy, Intravenous Radiotherapy, Oral Radiotherapy, and Systemic Radiotherapy. The External Beam Radiotherapy is further studied across 3D Conformal Radiotherapy, Image-Guided Radiotherapy, Intensity-Modulated Radiotherapy, Particle Therapy, and Stereotactic Therapy. The Internal Beam Radiotherapy or Brachytherapy is further studied across High-Dose-Rate Brachytherapy, Low-Dose-Rate Brachytherapy, and Pulsed-Dose-Rate Brachytherapy. The Systemic Radiotherapy is projected to witness significant market share during forecast period.
Based on Application, market is studied across Breast Cancer, Cervical Cancer, Colorectal Cancer, Gynecological Cancer, Head & Neck Cancer, Lung Cancer, Penile Cancer, and Prostate Cancer. The Prostate Cancer is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Hospitals and Independent Radiotherapy Centers. The Hospitals is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is an indispensable tool for assessing the Radiotherapy Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
The Market Share Analysis offers invaluable insights into the vendor landscape Radiotherapy Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
The report delves into recent significant developments in the Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Becton, Dickinson and Company, Elekta AB, General Electric Company, IBA Worldwide, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., Qfix, Radiology Oncology Systems, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.
1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast for the Radiotherapy Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Radiotherapy Market?
3. What is the competitive strategic window for identifying opportunities in the Radiotherapy Market?
4. What are the latest technology trends and regulatory frameworks in the Radiotherapy Market?
5. What is the market share of the leading vendors in the Radiotherapy Market?
6. Which modes and strategic moves are suitable for entering the Radiotherapy Market?